Percutaneous Sigmoid Fixation For Management Of Recurrent Sigmoid Volvulus

计划入组 66 人 · 首次发布于 2025 年 9 月 4 日

Quality of Life in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis

计划入组 136 人 · 首次发布于 2023 年 7 月 12 日

Treatment of Sigmoid Volvulus

计划入组 70 人 · 首次发布于 2025 年 1 月 13 日

COX-2 Inhibitors (Sublimity Therapeutics)

thalassemia therapeutics

PGTI-0306 based therapeutics (Phenogene Therapeutics)

Sigrid Therapeutics AB

Sweden

JASPER THERAPEUTICS, INC

United States

CRISPR Therapeutics, Inc.

United States

XtalPi's AI-Designed Peptide Receives US Safety Certification While Pan-TEAD Inhibitor Advances to Clinical Trials

Traveler's Diarrhea Therapeutics: Pipeline Analysis Highlights Novel Approaches

FDA Grants Dual Designations to NEU-001 for Hirschsprung Disease, Offering Hope for Non-Surgical Treatment